WeedAdvisor
JUNE 1, 2019
The court, citing concerns over marijuana’s Schedule I status and its impact on medical users who need it most, essentially issued an ultimatum to the DEA. Like a child who does not want to clean his or her room, the DEA simply refuses to take any major action, despite the whirlwind of reforms surrounding them on a daily basis.
Canna Law Blog
NOVEMBER 27, 2021
So according to the DEA, its abuse potential is high and it has no medical use. Also, according to the DEA, “the history of human experience probably goes back several hundred years since DMT usage is associated with a number of religious practices and rituals.” Special Forces Operations Veterans with promising results.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Cannabis Law Report
MAY 29, 2022
8] Spravato is derived from ketamine and categorized by DEA as a Schedule III controlled substance. FDA granted Breakthrough Therapy designation for Spravato in 2013 and ultimately approved it for adults who have not responded to treatment after trying other antidepressant medications. DEA and the Controlled Substances Act.
Canna Care Docs
SEPTEMBER 26, 2019
Powered by Sail, we are on a mission to solve the issue of cannabis access for patients. Since 2013, Canna Care Docs has expanded to over 25 locations representing 11 states. Canna Care Docs is the center of excellence for cannabis medicine. Evaluate patient for verification of a qualifying condition.
Canna Law Blog
JANUARY 11, 2022
The thought process goes that three things will reduce the illicit market: (1) federal and statewide legalization, (2) incentives to access the legal market, and (3) putting compliance ahead of enforcement. In 2013, the federal government sort of changed its tune with the Cole Memo. Prohibition, even combined with enforcement, failed.
The Herb Collective
JUNE 25, 2018
In 2013, of the estimated 22 million pounds of US grown marijuana each year, Kentucky, California, Tennessee, Hawaii, and Washington grew roughly 80% of all crops. Million in Medicare was saved in 2013 after states implemented medical marijuana laws. (Source: Leafly) 3. Source: Mother Jones) Medical Use of Marijuana 4.
Cannabis Law Report
APRIL 8, 2022
Later that year, Doblin sued the DEA for the first time. submitted his first DEA application to manufacture marijuana for use in medical research. Over 1,500 people from around the world attended MAPS’ Psychedelic Science 2013 conference in Oakland, CA. Lyle Craker, Ph.D., MAPS Founder Rick Doblin, Ph.D.,
Expert insights. Personalized for you.
55 
Let's personalize your content